𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Adjuvant Treatment of HER2-Positive Breast Cancer

✍ Scribed by Jelovac, Danijela; Wolff, Antonio C.


Book ID
113091411
Publisher
Springer
Year
2012
Tongue
English
Weight
130 KB
Volume
13
Category
Article
ISSN
1527-2729

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cost-effectiveness analysis of trastuzum
✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t